Literature DB >> 7923249

In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

A D Le Lann1, G J Fournié, L Boissier, P L Toutain, H Benoist.   

Abstract

A qualitative impairment of natural killer (NK) function and the presence of circulating DNA have been independently reported in clinical situations such as cancer and lupus. The existence of receptors for chromatin fragments at the leukocyte membrane raised the question of the relation between the presence of chromatin fragments in the extracellular medium and the impairment of NK function. The present study shows that plasmas from patients with metastatic cancer and with pathological DNA concentrations inhibited significantly the NK activity of normal lymphocytes as compared to cancer plasmas with DNA concentrations in the normal range. In vitro, it was demonstrated that chromatin fragments inhibited the NK-mediated cytotoxicity in a dose-dependent manner. Inhibitory concentrations of nucleosomes (2.5-10 micrograms/ml) were lower than those of DNA and histones alone (100 micrograms/ml). Inhibitory effects of nucleosomes, DNA and histones differed also according to the effector population used: nucleosomes were effective whatever the CD56+ cell enrichment of the effector population, while DNA inhibition needed T cells, and histone inhibition probably resulted from a subtoxic effect, prevented by the presence of adherent cells. Finally we found that nucleosomes could inhibit the NK function only when they were present in the extracellular medium. Taken together, these data suggest that the persistence of nucleosomal DNA at sites of cell death or in the blood might be responsible, at least partly, for the NK activity impairment observed in pathological circumstances characterized by a high rate of cell death phenomena such as cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923249     DOI: 10.1007/bf01533385

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  31 in total

1.  Adriamycin-induced resistance to natural killer (NK)-mediated cytotoxicity.

Authors:  W J Wood; E Lotzová
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

2.  Plasma DNA as cell death marker in elderly patients.

Authors:  G J Fournié; F Martres; J P Pourrat; C Alary; M Rumeau
Journal:  Gerontology       Date:  1993       Impact factor: 5.140

3.  In vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma.

Authors:  N E Dunlap; V G Lane; G A Cloud; A B Tilden
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

4.  Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production.

Authors:  S H Hefeneider; K A Cornell; L E Brown; A C Bakke; S L McCoy; R M Bennett
Journal:  Clin Immunol Immunopathol       Date:  1992-06

5.  Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells.

Authors:  A Skladanowski; J Konopa
Journal:  Biochem Pharmacol       Date:  1993-08-03       Impact factor: 5.858

6.  Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.

Authors:  P M Moy; E C Holmes; S H Golub
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

7.  Human peripheral blood monocytes display surface antigens recognized by monoclonal antinuclear antibodies.

Authors:  V M Holers; B L Kotzin
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

8.  Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.

Authors:  D Zippel; V Lackovic; D Kocisková; J Rovenský; L Borecký; A Stelzner
Journal:  Acta Virol       Date:  1989-09       Impact factor: 1.162

9.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.

Authors:  C Mohan; S Adams; V Stanik; S K Datta
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  Human autoantibodies that react with both cell nuclei and plasma membranes display specificity for the octamer of histones H2A, H2B, H3, and H4 in high salt.

Authors:  O P Rekvig; K Hannestad
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  4 in total

1.  Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

2.  DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.

Authors:  Markella Zannikou; Sofia Bellou; Petros Eliades; Aikaterini Hatzioannou; Michael D Mantzaris; George Carayanniotis; Stratis Avrameas; Peggy Lymberi
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

3.  Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.

Authors:  Catalina Trejo-Becerril; Luis F Oñate-Ocaña; Lucía Taja-Chayeb; América Vanoye-Carlo; Lucely Cetina; Alfonso Duenas-Gonzalez
Journal:  BMC Cancer       Date:  2005-06-27       Impact factor: 4.430

4.  Fragment size analysis of free fetal DNA in maternal plasma using Y-STR loci and SRY gene amplification.

Authors:  Machiko Kimura; Masaaki Hara; Atsuo Itakura; Chiaki Sato; Kenji Ikebuchi; Osamu Ishihara
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.